Torii Pharmaceutical Co., Ltd. (4551T) DCF Valuation

Torii Pharmaceutical Co., Ltd. (4551.T) Avaliação DCF

JP | Healthcare | Drug Manufacturers - Specialty & Generic | JPX
Torii Pharmaceutical Co., Ltd. (4551T) DCF Valuation
  • Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • Pré-Construídos Para Uso Rápido E Eficiente
  • Não É Necessária Experiência; Fácil De Seguir

Torii Pharmaceutical Co., Ltd. (4551.T) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Aprimore suas estratégias de investimento com a calculadora DCF (4551T)! Mergulhe nos dados financeiros mais recentes da Torii Pharmaceutical Co., Ltd., ajuste as projeções e despesas de crescimento e observe instantaneamente como essas modificações afetam o valor intrínseco de (4551t).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 41,699.0 46,987.0 48,894.0 54,638.0 60,426.0 57,634.5 54,972.0 52,432.5 50,010.3 47,700.0
Revenue Growth, % 0 12.68 4.06 11.75 10.59 -4.62 -4.62 -4.62 -4.62 -4.62
EBITDA 4,688.0 5,047.0 5,975.0 5,830.0 7,207.0 6,547.4 6,245.0 5,956.5 5,681.3 5,418.8
EBITDA, % 11.24 10.74 12.22 10.67 11.93 11.36 11.36 11.36 11.36 11.36
Depreciation 461.0 279.0 252.0 459.0 408.0 430.0 410.1 391.1 373.1 355.8
Depreciation, % 1.11 0.59378 0.5154 0.84007 0.67521 0.746 0.746 0.746 0.746 0.746
EBIT 4,227.0 4,768.0 5,723.0 5,371.0 6,799.0 6,117.5 5,834.9 5,565.3 5,308.2 5,063.0
EBIT, % 10.14 10.15 11.7 9.83 11.25 10.61 10.61 10.61 10.61 10.61
Total Cash 70,104.0 65,572.0 58,909.0 44,003.0 43,298.0 52,123.5 49,715.6 47,418.9 45,228.3 43,139.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 18,955.0 22,010.0 22,865.0 28,502.0 31,068.0
Account Receivables, % 45.46 46.84 46.76 52.17 51.41
Inventories 7,151.0 8,763.0 8,969.0 10,742.0 14,217.0 11,219.2 10,701.0 10,206.6 9,735.1 9,285.4
Inventories, % 17.15 18.65 18.34 19.66 23.53 19.47 19.47 19.47 19.47 19.47
Accounts Payable 5,143.0 5,793.0 6,584.0 6,981.0 10,448.0 7,860.9 7,497.7 7,151.4 6,821.0 6,505.9
Accounts Payable, % 12.33 12.33 13.47 12.78 17.29 13.64 13.64 13.64 13.64 13.64
Capital Expenditure -411.0 -374.0 -281.0 -216.0 -152.0 -346.2 -330.2 -314.9 -300.4 -286.5
Capital Expenditure, % -0.98564 -0.79596 -0.57471 -0.39533 -0.25155 -0.60064 -0.60064 -0.60064 -0.60064 -0.60064
Tax Rate, % 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01
EBITAT 3,496.7 3,374.7 3,944.7 3,955.5 5,098.2 4,539.9 4,330.1 4,130.1 3,939.3 3,757.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -17,416.3 -737.3 3,645.7 -2,814.5 2,780.2 8,132.9 5,857.3 5,586.7 5,328.6 5,082.5
WACC, % 5.25 5.25 5.25 5.25 5.25 5.25 5.25 5.25 5.25 5.25
PV UFCF
SUM PV UFCF 26,085.1
Long Term Growth Rate, % 3.00
Free cash flow (T + 1) 5,235
Terminal Value 232,830
Present Terminal Value 180,286
Enterprise Value 206,371
Net Debt -2,890
Equity Value 209,261
Diluted Shares Outstanding, MM 28
Equity Value Per Share 7,444.50

What You Will Receive

  • Genuine Torii Data: Preloaded financials – including revenue and EBIT – derived from actual and projected figures.
  • Comprehensive Customization: Modify key parameters (yellow cells) such as WACC, growth %, and tax rates.
  • Real-Time Valuation Updates: Automatic recalculations to assess the influence of changes on Torii Pharmaceutical’s fair value.
  • Flexible Excel Template: Designed for quick edits, scenario analysis, and in-depth projections.
  • Efficient and Precise: Bypass the need to build models from the ground up while ensuring accuracy and adaptability.

Key Features

  • Customizable Financial Inputs: Adjust essential variables such as revenue growth, EBITDA percentage, and capital expenditures.
  • Instant DCF Valuation: Automatically computes intrinsic value, net present value, and other financial metrics.
  • High-Precision Accuracy: Leverages Torii Pharmaceutical’s (4551T) actual financial data for realistic valuation results.
  • Simplified Scenario Analysis: Easily examine various assumptions and compare different outcomes.
  • Efficiency Booster: Streamlines the valuation process by removing the need for complex model construction.

How It Functions

  1. Obtain the Template: Gain immediate access to the Excel-based DCF Calculator for Torii Pharmaceutical Co., Ltd. ([4551T]).
  2. Enter Your Assumptions: Modify the yellow-highlighted cells to input growth rates, WACC, profit margins, and other relevant factors.
  3. Automatic Calculations: The model will instantly recalculate Torii’s intrinsic value based on your inputs.
  4. Explore Scenarios: Test various assumptions to see how they impact the potential valuation.
  5. Evaluate and Decide: Leverage the findings to inform your investment strategies or financial assessments.

Why Opt for This Calculator?

  • Designed for Experts: A sophisticated tool utilized by market analysts, financial officers, and industry consultants.
  • Comprehensive Data: Torii Pharmaceutical's historical and forecasted financials are preloaded for precision.
  • Scenario Analysis: Effortlessly simulate various projections and assumptions.
  • Detailed Insights: Instantly calculates intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Clear, step-by-step instructions guide you throughout the entire process.

Who Can Benefit from This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for assessing pharmaceutical investments.
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Equip clients with precise valuation insights for Torii Pharmaceutical Co., Ltd. (4551T).
  • Students and Educators: Utilize real-time data to enhance financial modeling skills and teaching methodologies.
  • Pharmaceutical Enthusiasts: Gain insights into the market valuation of leading pharmaceutical companies like Torii.

Contents of the Template

  • Historical Data: Features past financials and baseline forecasts for Torii Pharmaceutical Co., Ltd. (4551T).
  • DCF and Levered DCF Models: Comprehensive templates designed to assess the intrinsic value of Torii Pharmaceutical Co., Ltd. (4551T).
  • WACC Sheet: Standardized calculations for the Weighted Average Cost of Capital.
  • Editable Inputs: Adjust essential variables such as growth rates, EBITDA percentages, and CAPEX projections.
  • Quarterly and Annual Statements: A thorough analysis of the financial statements for Torii Pharmaceutical Co., Ltd. (4551T).
  • Interactive Dashboard: A dynamic visual representation of valuation outcomes and future projections.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.